Influenza, Human: all 2,264 studies

Page 3 of 23. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.

• Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza VaccinationsCompletedNCT06020118Phase 4Results posted
• Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable AdultsCompletedNCT05975840Phase 1/2Results posted
• A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).CompletedNCT05886777Phase 2Results posted
• Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy AdultsCompletedNCT05868382Phase 2Results posted
• This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.CompletedNCT05858450Results posted
• Study of mRNA-1010 Seasonal Influenza Vaccine in AdultsCompletedNCT05827978Phase 3Results posted
• A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsCompletedNCT05827926Phase 1/2Results posted
• A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy AdultsCompletedNCT05827068Phase 1/2Results posted
• A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older AdultsCompletedNCT05823974Phase 1/2Results posted
• MGC Health COVID-19 & Flu A+B Home Multi Test Usability StudyCompletedNCT05732610Not applicableResults posted
• A Study of the GRIP Influenza and SARS-CoV-2 POC AssaysCompletedNCT05674370Not applicableResults posted
• DMID 21-0041; Influenza CVD 59000CompletedNCT05666245Not applicableResults posted
• A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in IndiaCompletedNCT05648357Phase 4Results posted
• Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and OlderCompletedNCT05608005Phase 1/2Results posted
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and InfluenzaCompletedNCT05596734Phase 2Results posted
• A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and AboveCompletedNCT05568797Phase 3Results posted
• A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza ATerminatedNCT05567783Phase 2Results posted
• A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and OlderCompletedNCT05566639Phase 3Results posted
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or OlderCompletedNCT05540522Phase 3Results posted
• Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)CompletedNCT05535777Not applicableResults posted
• Patient Portal Flu Vaccine Reminders (5)CompletedNCT05525494Not applicableResults posted
• The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy AdultsCompletedNCT05523089Phase 2Results posted
• Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 YearsCompletedNCT05514002Phase 4Results posted
• Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 YearsTerminatedNCT05513391Phase 3Results posted
• Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.CompletedNCT05513053Phase 3Results posted
• Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge ModelCompletedNCT05507567Phase 2Results posted
• Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of AgeCompletedNCT05501561Phase 2Results posted
• High-risk Influenza Vaccine AlertCompletedNCT05492786Not applicableResults posted
• A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older AdultsCompletedNCT05446740Phase 1Results posted
• A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or UnprimedCompletedNCT05422326Phase 2Results posted
• A Study of mRNA-1010 Seasonal Influenza Vaccine in AdultsCompletedNCT05415462Phase 3Results posted
• A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy AdultsCompletedNCT05397119Phase 1Results posted
• A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years OldCompletedNCT05375838Phase 1/2Results posted
• A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy AdultsCompletedNCT05333289Phase 1/2Results posted
• Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With InfluenzaTerminatedNCT05170009Phase 2/3Results posted
• Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South KoreaCompletedNCT05144945Phase 3Results posted
• A Study of Ad26.COV2.S and Influenza Vaccines in Healthy AdultsCompletedNCT05091307Phase 3Results posted
• Beta-glucan and Immune Response to Influenza VaccineCompletedNCT05074303Phase 2Results posted
• A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and OlderCompletedNCT05071313Phase 3Results posted
• Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With AsthmaCompletedNCT05062759Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against InfluenzaCompletedNCT05052697Phase 1/2Results posted
• Patient Portal Flu Vaccine Reminders_RCT 4TerminatedNCT05052190Not applicableResults posted
• Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyCompletedNCT05050318Phase 4Results posted
• A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster VaccineCompletedNCT05047770Phase 3Results posted
• A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.CompletedNCT05045144Phase 3Results posted
• A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of AgeCompletedNCT05044195Phase 3Results posted
• Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza VaccineCompletedNCT05027932Phase 1Results posted
• Lottery Incentive Nudges to Increase Influenza VaccinationsCompletedNCT05012163Not applicableResults posted
• Using Explainable AI Risk Predictions to Nudge Influenza Vaccine UptakeCompletedNCT05009251Not applicableResults posted
• Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)CompletedNCT04978818Phase 4Results posted
• Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza StrainCompletedNCT04978454Phase 1Results posted
• Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 VaccineCompletedNCT04969276Phase 2Results posted
• Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza VaccineTerminatedNCT04960397Phase 1Results posted
• A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy AdultsCompletedNCT04956575Phase 1/2Results posted
• First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy AdultsCompletedNCT04896086Phase 1Results posted
• Study of SAB-176 in Healthy Adult ParticipantsCompletedNCT04850898Phase 2Results posted
• A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and OlderCompletedNCT04789577Phase 2Results posted
• Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years OldCompletedNCT04785794Phase 1Results posted
• Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older AdultsCompletedNCT04782323Phase 2Results posted
• Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.CompletedNCT04682444Phase 2/3Results posted
• A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza VaccineCompletedNCT04669691Phase 2Results posted
• Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)TerminatedNCT04664075Results posted
• Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and OlderCompletedNCT04622592Phase 1/2Results posted
• Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy AdultsCompletedNCT04579250Phase 1Results posted
• Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older AdultsCompletedNCT04576702Phase 2Results posted
• Testing Multiple Behavioral Science Strategies to Increase Flu-Shot RatesCompletedNCT04565353Not applicableResults posted
• Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyCompletedNCT04551677Phase 4Results posted
• Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgeTerminatedNCT04544267Phase 3Results posted
• Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and OlderCompletedNCT04537234Phase 3Results posted
• Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3CompletedNCT04533685Not applicableResults posted
• Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in IsraelCompletedNCT04523324Phase 4Results posted
• Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and OlderCompletedNCT04498832Phase 3Results posted
• Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy ParticipantsCompletedNCT04471038Phase 1Results posted
• Increasing Influenza and Tdap Vaccination of Pregnant WomenCompletedNCT04444518Not applicableResults posted
• Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory PathogensTerminatedNCT04431050Results posted
• Encouraging Flu Vaccination Among High-Risk Patients Identified by MLCompletedNCT04323137Not applicableResults posted
• Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus)CompletedNCT04204993Not applicableResults posted
• Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza VaccinationCompletedNCT04176133Phase 2Results posted
• Persuasion in Medicine: Experimental Evidence on Sender and Signal EffectsCompletedNCT04160975Not applicableResults posted
• Pilot of Cohort of Households for Influenza Monitoring and Evaluation in SeattleCompletedNCT04141930Phase 4Results posted
• Test-and-treat for Influenza in Homeless SheltersTerminatedNCT04141917Phase 4Results posted
• Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and OlderTerminatedNCT04137887Phase 3Results posted
• Phase 3 Pivotal Trial of NanoFlu™ in Older AdultsCompletedNCT04120194Phase 3Results posted
• Nasal and Systemic Immune Responses to Nasal Influenza VaccineCompletedNCT04110366Not applicableResults posted
• Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2CompletedNCT04110314Not applicableResults posted
• Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, RespectivelyCompletedNCT04109222Phase 4Results posted
• Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge VirusCompletedNCT04106817Phase 1Results posted
• Safety and Immunogenicity Study of QIVc in Healthy Pediatric SubjectsCompletedNCT04074928Phase 3Results posted
• H1N1v Virus Challenge Study in Healthy SubjectsCompletedNCT04044352Phase 1Results posted
• Systems Analyses of the Immune Response to the Seasonal Influenza VaccineCompletedNCT04025580Phase 2Results posted
• Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and OlderCompletedNCT04024228Phase 3Results posted
• Immunologic Response to FluMist vs. FlucelvaxCompletedNCT03982069Phase 4Results posted
• Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsCompletedNCT03969212Phase 3Results posted
• Flublok or Fluzone With Advax-CpG55.2 or AF03CompletedNCT03945825Phase 1Results posted
• Efficacy Study With QIVc in Pediatric SubjectsCompletedNCT03932682Phase 3Results posted
• Response to Influenza Vaccine During PregnancyTerminatedNCT03888989Phase 1Results posted
• Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge ModelCompletedNCT03883113Phase 2Results posted
• Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in AdultsTerminatedNCT03880474Phase 2Results posted
• Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in VolunteersCompletedNCT03849560Phase 2/3Results posted
• Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve IndividualsCompletedNCT03816878Phase 1Results posted

← Influenza, Human overview